Jakarta, CNBC Indonesia – Health Authority English (PHE) said two doses of the Covid-19 vaccine produced by two companies, Pfizer-BioNTech and AstraZeneca, were effective in dealing with the corona variant found in India.
Launch Reuters, in one of their studies, it was found that the Pfizer-BioNTech vaccine was 88% effective against symptomatic disease of variant B.1.617 two weeks after the second dose. Meanwhile, two doses of AstraZeneca vaccine are 60% effective against symptomatic diseases of the Indian variant.
Apart from the Indian variant, the two vaccines were also recorded as being effective against the British variant B.117 Covid. The Pfizer-BioNTech vaccine was 93% effective against the virus and AstraZeneca was 66% effective.
The UK Health Minister said the data was groundbreaking. He said he was increasingly hopeful that the government would be able to lift more restrictions next month.
“I am increasingly convinced that we are on the right track for the road map, because this data shows that the vaccine, after two doses, is equally effective (against the Indian variant),” said Health Minister Matt Hancock. ).
The UK has accelerated Europe’s fastest vaccination program so far. But Britain is facing new challenges from deploying a variant first discovered in India.
Data published on Saturday showed new Covid cases reported in the UK rose 10.5% in the seven days to May 22. Although it remains a fraction of the levels seen earlier this year.
(boss / boss)
– .
